Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial

Journal:

The BMJ

Published:

2025-06-04

DOI:

10.1136/bmj-2024-083735

Affiliations:

16

Authors:

27

Go to article

Institutions	Authors	Share
Nanfang Hospital, China	14.183333 14.183333	0.53
Southern Medical University (SMU), China	2.816667	0.10
The First Affiliated Hospital of Wenzhou Medical University, China	2.000000	0.07
Shenzhen People’s Hospital, China	2.000000	0.07
Zhongshan Hospital of Xiamen University, China	2.000000	0.07
Zhujiang Hospital of Southern Medical University, China	1.000000	0.04
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	1.000000	0.04
Foshan First People's Hospital, China	1.000000	0.04
Tulane University, United States of America (USA)	1.000000	0.04

Interested in Pharmacology and Pharmaceutical Sciences?